Internal Medicine, Gastroenterology · Florence, SC
NPI
1306895636
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
401 E Cheves St, Suite 301
Florence, SC, 29506
Phone (843) 777-7166
Groups this clinician bills Medicare through
Medicare paid, 2024
$165K
1,649 services
Medicare patients, 2024
912
Average age 73
Drug cost, 2024
$352K
1,769 prescriptions
Company payments, 2025
$692
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deepak Chowdhary was code 45385 (colonoscopy - lesion removal), 320 times for 316 patients. In total Deepak Chowdhary billed 1,649 services in 39 codes, and Medicare paid $165K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-05-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Facility | 320 | 316 | $181.95 | $58K |
| 43239 Upper GI Endoscopy | Facility | 186 | 174 | $73.03 | $14K |
| 99213 Office E&M - Established | Office | 162 | 130 | $56.41 | $9,139 |
| 99231 Hospital E&M - Subsequent | Facility | 150 | 81 | $36.60 | $5,490 |
| 99214 Office E&M - Established | Office | 101 | 93 | $80.64 | $8,145 |
| 45378 Lower GI Endoscopy - Other | Facility | 87 | 86 | $112.03 | $9,747 |
| 45380 Lower GI Endoscopy - Other | Facility | 75 | 75 | $100.05 | $7,504 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 56 | 56 | $170.02 | $9,521 |
| 99222 Hospital E&M - Initial | Facility | 54 | 52 | $97.45 | $5,262 |
| 99204 Office E&M - New | Office | 52 | 52 | $109.09 | $5,673 |
| 99213 Office E&M - Established | Facility | 52 | 48 | $48.29 | $2,511 |
| 99214 Office E&M - Established | Facility | 46 | 43 | $71.84 | $3,305 |
| 43235 Upper GI Endoscopy | Facility | 45 | 45 | $71.95 | $3,238 |
| 43249 Upper GI Endoscopy | Facility | 43 | 36 | $103.46 | $4,449 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 34 | 34 | $170.10 | $5,783 |
By year: 2022 $183K for 2,062 services; 2023 $171K for 1,933 services; 2024 $165K for 1,649 services.
Medicare prescription drug claims, 2024
In 2024, the drug Deepak Chowdhary prescribed most often to Medicare patients was Gavilyte-G (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 471 prescriptions and refills. In total Deepak Chowdhary wrote 1,769 Medicare prescriptions that cost $352K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 471 | 592 | 434 | $7,634 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 360 | 360 | 330 | $5,879 |
| Pantoprazole Sodium Generic | 249 | 623 | 105 | $3,464 |
| Sucralfate Generic | 101 | 186 | 46 | $4,775 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 84 | 84 | 84 | $5,572 |
| Mesalamine Generic | 45 | 75 | 12 | $17K |
| Dicyclomine Hcl Generic | 43 | 80 | 17 | $883 |
| Famotidine Generic | 33 | 85 | 12 | $453 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 32 | 32 | 32 | $859 |
| Cholestyramine Cholestyramine (With Sugar) | 27 | 29 | 13 | $1,447 |
| Linzess Linaclotide | 23 | 29 | Under 11 | $16K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 22 | 22 | 22 | $372 |
| Esomeprazole Magnesium Generic | 22 | 54 | Under 11 | $789 |
| Humira(Cf) Pen Adalimumab | 21 | 21 | Under 11 | $131K |
| Xifaxan Rifaximin | 21 | 21 | Under 11 | $73K |
Brand drugs: 545 claims; generic drugs: 1,224 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deepak Chowdhary $692 ($692 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $200.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 9 | $200 |
| Madrigal Pharmaceuticals MDGL | 4 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $116 |
| Genzyme Corporation SNY | 3 | $92.29 |
| Celltrion USA Inc. 068270.KS | 2 | $30.28 |
| Gilead Sciences, Inc. GILD | 1 | $19.79 |
| Pfizer Inc. PFE | 1 | $16.57 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $16.48 |
| Intercept Pharmaceuticals, Inc. | 1 | $15.93 |
| Olympus America Inc. | 1 | $15.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.